Of all the possible side effects that come with taking a GLP-1, losing your hair is perhaps one of the scariest. The good ...

WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; ...

A shortage of laboratories, equipment and chemicals continues to undermine student performance in science subjects across the ...

This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut ...

Viking Therapeutics targets obesity and MASH with high-risk prospects, trial concerns, and strong funding, but lags leaders ...

Health care professionals may prescribe GLP-1s for people with diabetes and binge eating disorder with strong psychotherapy support, a slow dose titration and close follow-up after initiation, ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut probiotic Christensenella ...

By seeing yourself with grace, you create an internal safe space where you can grow. You can love your shadow and feel unconditional love, When you have your own back, you’ll feel braver to take the ...

Lilly’s cardiovascular outcomes trial is the first to use an active comparator, finding noninferiority but not superiority of tirzepatide to dulaglutide in CV outcomes.